Home page - News - HTA Co., Ltd. and College of Chemistry of Beijing Normal University held a technical cooperation exchange meeting.
HTA Co., Ltd. and College of Chemistry of Beijing Normal University held a technical cooperation exchange meeting.
On March 30, 2022, the technical exchange meeting between HTA and the College of Chemistry of Beijing Normal University was held in the conference room of HTA. Beijing Normal University secretary of the College of Chemical Party committee Lu Zhonglin,

  On March 30, 2022, the technical exchange meeting between HTA and the College of Chemistry of Beijing Normal University was held in the conference room of HTA. Beijing Normal University secretary of the College of Chemical Party committee Lu Zhonglin, president Fan Louzhen, vice president Zhang Junbo and eight people came to carry out technical cooperation and exchange. HTA General manager Zhao Jing, deputy general manager Sui Yanying, head of R & D department, chief experts, technical leaders and training objects, technical backbone attended the meeting, deputy general manager Sui Yanying presided over the meeting and gave a welcome speech.

  图片4

  At the meeting, Professor Zhao Changgui and three other teachers from the College of Chemical of Beijing Normal University respectively made reports entitled "Synthesis and Diversity transformation of natural products", "Synthesis and Performance Research of Photodynamic Treatment of photosensitive drugs", and "Research on PET probes related to Alzheimer's disease"; Cheng Weihua and other three doctors from the research and Development Department of Atomic High Science made relevant technical reports based on the current research work. The two sides had a warm exchange and discussion on the frontier hot spots in the field of drug dosing, the transformation of achievements and drug registration.

  图片5

  After the meeting, the delegation of the College of Chemical of Beijing Normal University visited the atomic high science radiopharma research and development laboratory and production site.Both sides agreed that they would further refine various specific measures in future cooperation, increase the input of all parties, strive to achieve practical results, jointly promote the research and development of radioactive innovative drugs, and lead the development of national nuclear medical and health industry.

Prev: Next: